The renowned organization, PrimeCell Therapeutics LLC announced here today about its earnest effort and zeal in providing research support and pre-clinical studies destined for a clinical trial for the imperative assessment of the safety, in conjunction with the likelihood and effectiveness of the implanting autologous bone marrow stem cells into the distinct group of patients affected by the Spinal Cord Injury or the SCI. It has been stated in this regard, that in a noteworthy convention of the International Society for Cellular Therapy that happened in the last month in Australia the revered Dr. Luis Geffner presented an introductory but viable report.

While speaking to the concerned persons over this it has been revealed that in the specific time period ranging from the May 2006 to January 2007, a number of patients amounting to 25 highly affected from the syndrome of Spinal Cord Injury or SCI had to undergo a detailed treatment at the Luis Vernaza Hospital in Guayaquil in Ecuador. The kind of treatment that was applied there include autologous bone marrow stem cells, that certainly mean that the cells were extracted from the patients' own bone marrow, since there was hardly any other way out. Among the affected patients, total number of fifteen patients forming about 60 percent of the entire folk. Furthermore, there were ten patients forming about 40 percent who were capable of walking on the parallels with braces and seven (28 percent) could walk without braces, and four (16 percent) were found walking with crutches. The definite process was considered as a great success since no such undesirable episode was observed, while on the other hand the patients were found conforming brisk improvements in sensitivity, motility, bladder sensation, even controlling sphincters, erection and ejaculation.

While speaking to Dr. Geffner, the venerated Director of the Stem Cell Program at the Junta de Beneficencia de Guayaquil he said,   "These preliminary results, while encouraging, must be interpreted cautiously and prudently, and we must continue work examining the benefits of surgically implanted autologous bone marrow stem cells to patients with spinal cord injuries."

Again Silva, the revered vice president of research and development for PrimeCell Therapeutics said, "There is evidence demonstrating significant improvement in the quality of life of patients receiving the treatment, including spinal cord regeneration and additional clinical improvements following these stem cell transplants."   "More research is needed, of course, but this is very encouraging. Our ultimate goal, as always, is not just research - but research that will lead to timely viable therapies," he concluded.